Tri Dattwyler kertoo yleensä julkisuudessa ettei borrelioosi kroonistu ja antibioottihoito on tehokasta, diagnostiikka luotettavaa jne. Patenttihakemuksessaan hän kuitenkin tunnustaa borrelioosin diagnostiikan olevan riittämätöntä, taudin kroonistuvan ja antibioottihoitojen olevan usein tehottomia kroonisissa tapauksissa.
2000, updated 2007.
http://patft.uspto.gov/netacgi/nph-Pars ... L/borrelia
Patent: Recombinant constructs of Borrelia burgdorferi
Inventors: Dattwyler; Raymond J. (Setauket, NY), Gomes-Solecki; Maria J. C. (New York, NY), Luft; Benjamin J. (East Setauket, NY), Dunn; John J. (Bellport, NY)
"Currently, Lyme Disease is treated with a range of antibiotics, e.g., tetracyclines, penicillin and cephalosporins. However, such treatment is not always successful in clearing the infection. Treatment is often delayed due to improper diagnosis with the deleterious effect that the infection proceeds to a chronic condition, where treatment with antibiotics is often not useful. One of the factors contributing to delayed treatment is the lack of effective diagnostic tools."
BORRELIOOSIN KROONISTUMINEN
Valvojat: Jatta1001, Borrelioosiyhdistys, Bb